← Back to Clinical Trials
RecruitingNCT05903898

Improving Stroke Care in North-Norway Through Artificial Intelligence

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionIschemic Stroke
SponsorUniversity Hospital of North Norway
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment1,000
SexALL
Min Age18 Years
Max AgeN/A
Start Date2023-06-01
Completion2025-10-31
Interventions
AI software StrokeSens (Circle NVI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion (MeVO) in Northern Norway. Relevant outcomes will be compared between centres with and without available software during the study period.

Eligibility Criteria

Inclusion Criteria: * Patients with acute stroke symptoms admitted to a participating hospital within 24 hours of symptom onset Exclusion Criteria: * Patients not available for follow-up assessments (e.g. non-resident)

Related Trials